Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Akero Therapeutics Inc shares valued at $1,581,994 were sold by Cheng Andrew on Feb 10 ’25. At $52.73 per share, Cheng Andrew sold 30,000 shares. The insider’s holdings dropped to 686,062 shares worth approximately $34.7 million following the completion of this transaction.
Also, Graham G. Walmsley purchased 200,000 shares, netting a total of over 9,600,000 in proceeds. Following the buying of shares at $48.00 each, the insider now holds 1,000,000 shares.
Before that, Rolph Timothy had sold 18,750 shares from its account. In a trade valued at $1,059,630, the Chief Scientific Officer traded Akero Therapeutics Inc shares for $56.51 each. Upon closing the transaction, the insider’s holdings decreased to 18,750 shares, worth approximately $8.61 million.
As published in a research note from BofA Securities on January 30, 2025, Akero Therapeutics Inc [AKRO] has been rated up from a Neutral to a Buy and the price target has been revised to $63 from $35. Analysts at H.C. Wainwright resumed the stock at ‘”a Buy”‘ outlook in a report released in late January. As of November 18, 2024, Citigroup has initiated its “Buy” rating for AKRO.
Analyzing AKRO Stock Performance
During the last five days, there has been a surge of approximately 2.31%. Over the course of the year, Akero Therapeutics Inc shares have jumped approximately 81.81%. Shares of the company reached a 52-week high of $58.40 on 01/27/25 and a 52-week low of $21.34 on 01/14/25. A 50-day SMA is recorded $36.45, while a 200-day SMA reached $28.82. Nevertheless, trading volume fell to 0.81 million shares from 0.6 million shares the previous day.
Support And Resistance Levels for Akero Therapeutics Inc (AKRO)
According to the 24-hour chart, there is a support level at 50.00, which, if violated, would cause prices to drop to 49.42. In the upper region, resistance lies at 51.28. The next price resistance is at 51.97. RSI (Relative Strength Index) is 63.23 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.06, which suggests the price will decrease in the coming days. Percent R is at 78.18%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
